Pressure Biosciences Inc (PBIO)

[ngc1624_2]

With the reverse split PBIO will have only a little over 1 million shares outstanding. To me, that seems really low and leaves a lot of room for share price appreciation in the long run. I am wondering if anyone else sees it that way. That being said, I expect them to issue more shares in the near future.
It will be interesting to see the knee-jerk reaction the market has to the split. The split is not to avoid a delisting. but to gain an uplist to the Nasdaq Capital market. Anybody who didn't know the split was coming has not researched PBIO.
The key thing we can hope for is that they start showing profit soon. Richard has stated more than once that PBIO feels that they are undervalued by the market. While as a shareholder I feel the same way, I believe that until they actually show some profit, we likely won't see any substantial or sustainable gains.
As for the science, I believe anybody who does sample preparation is handicapping their own research by not using PBIO's machines. The researcher may be destroying the very thing they need to find by using the outdated and mostly destructive methods currently in use.
I doubled my position to 75,000 shares when the price sat at .15 to lower my average to .27. I hope the market at least lets me stay even at the start of this new beginning for Pressure Biosciences.
GLTA